As of November 2024, Amphastar Pharmaceuticals has a market cap of $2.33B. This makes Amphastar Pharmaceuticals the world's 4710th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.61B | -12.04% |
2023 | $2.96B | 120.74% |
2022 | $1.34B | 20.31% |
2021 | $1.12B | 15.81% |
2020 | $963.42M | 4.25% |
2019 | $924.13M | -3.07% |
2018 | $953.36M | 3.43% |
2017 | $921.74M | 4.45% |
2016 | $882.45M | 29.44% |
2015 | $681.72M | 22.57% |
2014 | $556.20M | - |